-
Study aim
-
Evaluation of the effect of natural pomegranate juice on inflammatory biomarkers and CBC in patients with Covid 19
-
Design
-
Clinical trial with control group, with parallel groups, double-blind, randomized, on 48 patients with Covid 19, Randomization will be done with block random sampling
-
Settings and conduct
-
This study will be performed in 48 patients with Covid-19 in Shahid Jalil Hospital in Yasuj. Patients are randomly divided into intervention and placebo groups and will receive pomegranate juice or placebo daily for 14 days. At the beginning and end of the study, the desired variable will be examined.
-
Participants/Inclusion and exclusion criteria
-
48 patients with Covid 19 based on definitive diagnosis of PCR, admitted to Shahid Beheshti Hospital in Yasuj will be included in the study based on admission and non-admission
Inclusion criteria: (1) Written informed consent form, (2) Age 18 years old or above, (3) Definitive diagnosis of Covid 19, (4) Acceptance for random assignment, (5) Willingness to participate in research study
Non-inclusion criteria: (1) Pregnancy or lactation, (2) Other contraindications prescribed by the specialist, (6) Participate in any clinical trial
-
Intervention groups
-
The intervention group will receive daily 500 ml of natural pomegranate juice and the placebo group will receive daily 500 ml of water + authorized food coloring + 0.02% pomegranate emulsion, twice a day for 14 days.
-
Main outcome variables
-
Inflammatory biomarker include IL-6 , CRP, ESR and CBC